AI assistant
Sending…
CellaVision — Major Shareholding Notification 2018
Jul 23, 2018
3025_iss_2018-07-23_057d6c43-5bcb-4429-b274-c910603b2434.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer CellaVision AB
Holder
William Demants og Hustru Ida Emilies Fond - kaldet Oticon-fonden
Instrument
| Instrument | Shares SE0000683484 |
|---|---|
| Before the transaction | |
| Shares | 2,374,802 |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 20/07/2018 |
| Limit for number of shares | 10 % |
| Limit for number of votes | 10 % |
| After the transaction | |
| Quantity | |
| Shares | 2,427,302 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 2,427,302 |
| Percentage | |
| Directly held shares | 10.17671 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 10.17671 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 10.17671 % | 2,427,302 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
Total 10.17671 % 2,427,302
| Chain of controlling companies | |||
|---|---|---|---|
| Voting rights |
% Voting rights |
Company | |
| 0 | 0 | William Demants og Hustru Ida Emilies Fond - kaldet Oticon fonden |
|
| 2,427,302 10.17671 | William Demant Invest A/S | ||
| Group total holdings | |||
| Voting rights | 2,427,302 | ||
| Percentage of voting rights 10.17671 |
Published
23/07/2018 09:51 Contact
Name Pelle Munk-Poulsen Phone +4539177300 Email [email protected]
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from CellaVision
Board/Management Information
2026
Jun 5
Board/Management Information
2026
Jun 5
AGM Information
2026
Apr 28
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 28
Interim / Quarterly Report
2026
Apr 24
Interim / Quarterly Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 16
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Mar 25